Identity
Transcription
Various mRNA isoforms were found in SUP-T3 and in the mouse, which also encompass upstream exons; gene products, however, always corresponded to the TAL2 protein encoded by exon 4.
Protein
Description 108 amino acids; basic Helix Loop Helix motif for protein dimerization and DNA-binding.
Expression
In adult testes; in developing midbrain, dorsal diencephalon, rostroventral diencaphalic/ telencephalic boundary, and anterior pons; pivotal role in the development of the mature central nervous system; not expressed during normal hematopoietic development.
Function
Transcription factor; TAL2 dimerizes with members of the class A subgroup of bHLH proteins (ie E47, E12, E2-2, HEB), as well as LIM-only proteins LMO1 and LMO2; heterodimers are formed intracellularly through stable interaction between bHLH domains of TAL2 and E47; TAL2/E47 heterodimers bind DNA in a sequencespecific manner that is dependent on the E-box element; TAL2/E12 heterodimers also have DNAbinding activity; TAL2 does not bind DNA in absence of E2A proteins; a significant fraction (60%) of TAL2 polypeptides from SUP-T3 exist in phosphorylated form, the rest is unphosphorylated; serine residue 100 of TAL2 is the potential site of phosphorylation by MAP kinases.
Homology
TAL1 at 1p31, LYL1 at 19p13; TAL2, TAL1, and LYL1 share more than 85% amino acid identity in the bHLH domain and are thus more related to one other than to other bHLH proteins, for instance c-myc.
Implicated in t(7;9)(q34;q32) -->TAL2-TCRB
Disease T cell acute lymphoblastic leukemia found in < 1% of ALL, in 1-2% of T-ALL, rare but recurrent. Hybrid/Mutated gene Translocation of part of TCRB locus to a breakpoint 33 kb downstream of TAL2 mediated by the V(D)J recombinase via a fortuitous recombination signal sequence (YRSS) on chromosome 9; the translocation results in a signal joint fusion of TAL2 YRSS with the Db1 23-RSS; this gene product was detected in 6 of 10 thymus samples of healthy children with an estimated frequency of 1 in 10 million thymic cells; only upon secondary rearrangement of the TAL2/Db signal joint to the Jb2.6 segment, and deletion of the intervening sequence, the typical TAL2/Jb2.6 T-ALL junctions could be observed which presumably lead to overexpression of TAL2 and development of leukemia. Vanura K Atlas Genet Cytogenet Oncol Haematol. 2005; 9(4) Abnormal protein TAL2 placed under control of TCRB enhancer leading to overexpression of TAL2 in T-cells and development of leukemia.
TAL2 (T-cell acute lymphoblastic leukemia 2)

